DrugPatentWatch Database Preview
POLOCAINE-MPF Drug Profile
» See Plans and Pricing
Which patents cover Polocaine-mpf, and when can generic versions of Polocaine-mpf launch?
Polocaine-mpf is a drug marketed by Fresenius Kabi Usa and is included in three NDAs.
The generic ingredient in POLOCAINE-MPF is mepivacaine hydrochloride. There are six drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the mepivacaine hydrochloride profile page.
Summary for POLOCAINE-MPF
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 3 |
| Suppliers / Packagers: | 2 |
| Bulk Api Vendors: | 89 |
| Patent Applications: | 594 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | POLOCAINE-MPF at DailyMed |
Pharmacology for POLOCAINE-MPF
| Drug Class | Amide Local Anesthetic |
| Physiological Effect | Local Anesthesia |
US Patents and Regulatory Information for POLOCAINE-MPF
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fresenius Kabi Usa | POLOCAINE-MPF | mepivacaine hydrochloride | INJECTABLE;INJECTION | 089406-001 | Dec 1, 1986 | AP | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| Fresenius Kabi Usa | POLOCAINE-MPF | mepivacaine hydrochloride | INJECTABLE;INJECTION | 089408-001 | Dec 1, 1986 | AP | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| Fresenius Kabi Usa | POLOCAINE-MPF | mepivacaine hydrochloride | INJECTABLE;INJECTION | 089409-001 | Dec 1, 1986 | AP | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
